How Much Does Jatenzo Cost in Tennessee in 2026?

Tennessee Retail Pricing for Jatenzo

The average cash-pay price for Jatenzo at Tennessee retail pharmacies sits at approximately $900 per month in 2026, matching the manufacturer list price set by Tolmar. This figure reflects the wholesale acquisition cost (WAC) for a 30-day supply of twice-daily capsules.

Pricing varies somewhat between pharmacy chains. Large retailers such as CVS and Walgreens in Nashville, Memphis, and Knoxville tend to price near the WAC, while independent pharmacies may charge a modest markup. The FDA approved Jatenzo (oral testosterone undecanoate) in March 2019 as the first oral testosterone replacement therapy for adult men with hypogonadism caused by specific medical conditions 1. The key registration trial by Swerdloff et al. demonstrated that 87% of men on Jatenzo achieved eugonadal testosterone levels (between 300 and 1 to 100 ng/dL) at the 237 mg twice-daily dose 2. That efficacy profile is what keeps demand steady despite the high list price.

GoodRx and similar discount platforms sometimes display prices between $820 and $950 for Tennessee ZIP codes, but these are not insurance prices. They reflect negotiated cash-discount rates. Patients should confirm the exact price with their local pharmacy before filling.

TennCare and Tennessee Medicaid Coverage

TennCare does not cover Jatenzo for standard male hypogonadism. The program's preferred drug list (PDL) restricts brand-name testosterone products, favoring generic injectable testosterone cypionate, which costs between $30 and $75 per month 3. The Endocrine Society's 2018 clinical practice guideline for testosterone therapy in men with hypogonadism recommends treatment when serum total testosterone is consistently below 300 ng/dL on morning draws, but does not mandate any particular formulation 4.

TennCare does have narrow exceptions. Coverage may apply for patients with a documented type 2 diabetes diagnosis who meet specific criteria, though approvals are rare and require extensive documentation from the prescribing provider. The American Urological Association has noted that oral testosterone undecanoate offers advantages for patients who cannot tolerate injections or topical gels 5.

For TennCare enrollees, the practical path forward is usually one of three options: switch to generic injectable testosterone cypionate, apply for the Tolmar patient assistance program, or explore compounded oral testosterone undecanoate through a licensed 503A pharmacy.

Commercial Insurance Coverage in Tennessee

Several major commercial insurers operating in Tennessee, including BlueCross BlueShield of Tennessee, Cigna, UnitedHealthcare, and Aetna, may cover Jatenzo after prior authorization. The typical approval criteria mirror the Endocrine Society guideline thresholds: two separate morning serum testosterone levels below 300 ng/dL, a documented etiology of hypogonadism, and failure of or contraindication to at least one first-line therapy 4.

Step therapy is common. Most plans require documentation that the patient tried and failed generic testosterone cypionate injections or topical testosterone gel before approving Jatenzo. A 2020 analysis in the Journal of the Endocrine Society found that prior authorization requirements delayed testosterone therapy initiation by a median of 14 days 6.

Even with approval, copays on specialty tiers can be significant. Tennessee patients with commercial coverage often face copays of $75 to $200 per month before applying manufacturer coupons. The Tolmar savings card (discussed below) can offset much of this cost for commercially insured patients. The FDA label notes Jatenzo should be taken with food, as absorption increases approximately 2- to 5-fold when taken with a fat-containing meal compared to fasting conditions 1.

The Tolmar Savings Card Program

Tolmar's copay assistance program is the single most effective tool for reducing out-of-pocket Jatenzo costs in Tennessee. Eligible patients with commercial insurance can pay as little as $0 per month, with the card covering up to a set annual maximum (terms are updated periodically on the Tolmar website).

Eligibility requirements are straightforward. The patient must have commercial insurance that covers Jatenzo (even at a high copay), must not be enrolled in any federal healthcare program (Medicare, Medicaid, TRICARE, VA), and must be a resident of the United States. Tennessee patients who meet these criteria can activate the card online or through their prescriber's office.

The savings card does not reduce the pharmacy's reimbursement. It functions as a secondary payer that covers the patient's cost-sharing obligation. Swerdloff et al. reported that adherence to oral testosterone undecanoate was higher than adherence to injectable formulations in the clinical trial setting, partly because of the convenience of oral dosing 2. Cost barriers can erode that adherence advantage. A claims-based study published in 2021 found that men on brand-name testosterone formulations had a 12-month discontinuation rate of 42% when monthly out-of-pocket costs exceeded $100 7.

Patients on Medicare Part D or Tennessee Medicaid are not eligible for the savings card. These individuals should contact Tolmar's patient assistance program directly, as separate programs with different income-based criteria may apply.

Compounded Oral Testosterone Undecanoate in Tennessee

Licensed 503A compounding pharmacies in Tennessee can legally prepare oral testosterone undecanoate capsules for individual patients with valid prescriptions. This route can reduce monthly costs significantly, sometimes to under $100 per month depending on the pharmacy and dose.

Tennessee follows the Federal Food, Drug, and Cosmetic Act sections 503A and 503B for compounding oversight. A 503A pharmacy must compound pursuant to a patient-specific prescription, use USP-grade ingredients, and comply with Tennessee Board of Pharmacy regulations 8. The FDA's guidance on compounding from bulk drug substances specifies that compounders must not produce copies of commercially available drugs except under specific conditions 9.

Bioequivalence is the key concern. Compounded capsules are not FDA-approved and do not undergo the same rigorous bioavailability testing as Jatenzo. The Jatenzo formulation uses a proprietary self-emulsifying drug delivery system (SEDDS) that enhances lymphatic absorption and avoids first-pass hepatic metabolism 10. Compounded versions may not replicate this delivery technology, which could lead to different absorption profiles and serum testosterone levels.

Patients choosing a compounded alternative should insist on regular monitoring. The Endocrine Society recommends checking serum testosterone levels 3 to 6 months after starting therapy and then annually 4. A hematocrit check is also recommended, given that testosterone therapy can increase red blood cell mass: the FDA label for Jatenzo reports a hematocrit increase above 54% in approximately 3.1% of treated men 1.

Telehealth Prescribing of Jatenzo in Tennessee

Tennessee permits telehealth prescribing of Jatenzo. The state's telehealth laws, updated following the COVID-19 public health emergency expansions, allow providers to prescribe Schedule III controlled substances (testosterone is Schedule III under the DEA) via audio-video telehealth encounters 11. The prescriber must be licensed in Tennessee or hold a valid multistate medical license recognized by the Tennessee Board of Medical Examiners.

Telehealth-based testosterone therapy has expanded access for patients in rural parts of Tennessee. According to the FDA, Jatenzo's oral formulation may be particularly well-suited to telehealth management because it does not require in-office injection training or topical application instruction 1. The American Association of Clinical Endocrinology (AACE) has emphasized that laboratory monitoring remains essential regardless of the prescribing modality, with baseline and follow-up labs including total testosterone, hematocrit, PSA, and a lipid panel 12.

Patients should verify that their telehealth provider can send prescriptions to their preferred Tennessee pharmacy. Some national telehealth platforms partner with specific pharmacy networks, and Jatenzo may not be stocked at all locations.

How Jatenzo Compares to Other Testosterone Formulations on Cost

Within Tennessee, the cost spectrum for testosterone replacement therapy is wide. Generic testosterone cypionate (injectable) costs $30 to $75 per month without insurance. Topical testosterone gel (generic AndroGel 1.62%) runs approximately $60 to $150 per month 13. Testosterone nasal gel (Natesto) costs roughly $500 to $700 per month. Jatenzo, at $900, sits at the upper end.

The trade-off is convenience and patient preference. A 2021 study in the Journal of Urology surveyed 150 hypogonadal men and found that 68% expressed a preference for an oral formulation over injections when cost was equalized 5. The cardiovascular safety profile also matters. The TRAVERSE trial (N=5,246), published in the New England Journal of Medicine in 2023, demonstrated that testosterone replacement therapy did not increase the incidence of major adverse cardiovascular events compared to placebo in men aged 45 to 80 with hypogonadism and preexisting or high risk for cardiovascular disease 14. While TRAVERSE used a topical gel formulation, the FDA has applied its safety conclusions broadly to testosterone products, including Jatenzo.

For Tennessee patients on a tight budget who still want an oral option, compounded oral testosterone undecanoate remains the primary alternative. Those with commercial insurance should explore the Tolmar savings card before defaulting to injectables.

Strategies to Lower Your Jatenzo Cost in Tennessee

Start with the Tolmar savings card if you have commercial insurance. Contact your insurer to confirm formulary placement and prior authorization requirements before your first fill. If denied, ask your prescriber to submit a peer-to-peer review or a formal appeal citing clinical necessity and prior formulation failure.

For patients without insurance, check independent pharmacies in the Nashville and Memphis metro areas, as these sometimes negotiate lower wholesale prices. Rx discount platforms can shave $50 to $80 off the cash price. The 2019 Endocrine Society position statement on testosterone therapy access noted that out-of-pocket cost remains the primary barrier to long-term adherence for branded formulations 4.

If cost remains prohibitive, discuss compounded oral testosterone undecanoate with your prescriber. Ensure the compounding pharmacy is licensed by the Tennessee Board of Pharmacy and follows USP 795 and USP 800 standards for non-sterile and hazardous drug compounding 8. Monitor serum testosterone and hematocrit at 3, 6, and 12 months after starting therapy, then annually 4.